Saturday, 31 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
New Order Win

Orchid Pharma Bags ₹169.1 Cr Order

Orchid Pharma signed a licensing deal with Russia's Pharmasyntez, unlocking a $178M opportunity. This 10-year pact for Exblifep® marks a major international expansion for the Indian pharma firm.

Key figures
Value₹169.1 Cr
Execution period10 years
Source

NSE filing, NSE: ORCHPHARMA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Orchid Pharma Ltd: key numbers

Share price
₹836.45
Market cap
₹5,009 Cr
Revenue (annual)
₹811.3 Cr
Net profit (annual)
₹20.55 Cr
P/E (TTM)
577.9×Sector 45.9×
Promoter holding
74.45%+4.61% QoQ
FII holding
0.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Orchid Pharma Ltd

All →
17:03 IST BSE
Partnership

Orchid Pharma Partnership

Orchid Pharma entered a licensing and supply agreement with Laboratorio Libra for Exblifep across nine Latin American markets. The partnership is expected to represent a potential opportunity of about USD 80 million over 10 years.

12:13 IST BSE
Fund Raise

Orchid Pharma Fund Raise of ₹600 Cr

Orchid Pharma's board approved an enabling resolution to raise funds of up to ₹600 Crore through equity or debt securities via various permissible modes.

Value
₹600.0 Cr

Other new order win announcements

All →